Are you Dr. Pisters?
Join over one million U.S. Physicians, Nurse Practitioners and PAs, already on Doximity.
- Gain access to free telehealth tools, such as our "call shielding" and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
You already have 56 invites waiting! - Read the latest clinical news, personalized to your specialty.
Office
1515 Holcombe Blvd
Unit 1373
Houston, TX 77030Phone+1 713-792-3250
Summary
- Dr. Louis Pisters, MD is a board certified urologist in Houston, Texas. He is currently licensed to practice medicine in Texas, Alabama, and Arizona. He is affiliated with University of Texas M.D. Anderson Cancer Center and is a Professor at Division of Surgery.
Education & Training
- University of Texas Health Science Center at HoustonResidency, Urology, 1991 - 1993
- University of FloridaResidency, Urology, 1988 - 1991
- University of FloridaResidency, Surgery, 1986 - 1988
- University of Western OntarioClass of 1986
Certifications & Licensure
- AZ State Medical License 2024 - 2027
- TN State Medical License 2024 - 2026
- GA State Medical License 2024 - 2025
- LA State Medical License 2024 - 2025
- MS State Medical License 2024 - 2025
- OK State Medical License 2020 - 2025
- TX State Medical License 1991 - 2025
- American Board of Urology Urology
- Join now to see all
Awards, Honors, & Recognition
- America's Top Doctors Castle Connolly, 2008-2014
- Top Doctors:SE Texas Castle Connolly, 2013
- America's Top Doctors for Cancer Castle Connolly, 2005-2013
- Join now to see all
Publications & Presentations
PubMed
- 1577 citationsQuality of life and satisfaction with outcome among prostate-cancer survivors.Martin G. Sanda, Rodney L. Dunn, Jeff M. Michalski, Howard M. Sandler, Laurel L. Northouse
The New England Journal of Medicine. 2008-03-20 - 136 citationsLymph Node Density Is Superior to TNM Nodal Status in Predicting Disease-Specific Survival After Radical Cystectomy for Bladder Cancer: Analysis of Pooled Data From MD...Wassim Kassouf, Piyush K. Agarwal, Harry W. Herr, Mark F. Munsell, Philippe E. Spiess
Journal of Clinical Oncology. 2008-01-01 - 50 citationsPhase III Prevention Trial of Fenretinide in Patients with Resected Non–Muscle-Invasive Bladder CancerAnita L. Sabichi, Seth P. Lerner, E. Neely Atkinson, H. Barton Grossman, Nancy P. Caraway
Clinical Cancer Research. 2008-01-01
Press Mentions
- Salvage Cryotherapy for Recurrent PCa May Provide Long-Term Oncologic ControlMay 4th, 2021
- Pathology Report Gives Prostate Cancer Survivor More Treatment OptionsDecember 10th, 2018
Professional Memberships
- Member